HC Wainwright Expects Stronger Earnings for Bausch + Lomb

Bausch + Lomb Corporation (NYSE:BLCO) – Research analysts at HC Wainwright increased their Q1 2027 EPS estimates for Bausch + Lomb in a research note issued to investors on Monday, November 2nd. HC Wainwright analyst Y. Chen now forecasts that the company will earn $0.16 per share for the quarter, up from their previous estimate of $0.12. HC Wainwright currently has a “Neutral” rating and a $22.00 target price on the stock. The consensus estimate for Bausch + Lomb’s current full-year earnings is $0.94 per share. HC Wainwright also issued estimates for Bausch + Lomb’s Q2 2027 earnings at $0.29 EPS.

Bausch + Lomb (NYSE:BLCO) last released its quarterly earnings results on Wednesday, October 28th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.13. The business had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.37 billion. Bausch + Lomb had a negative net margin of 2.05% and a positive return on equity of 5.02%. The business’s revenue was up 7.3% on a year-over-year basis. During the same period last year, the business earned $0.18 EPS.

BLCO has been the subject of a number of other reports. Royal Bank Of Canada upped their price objective on shares of Bausch + Lomb from $21.00 to $23.00 and gave the company an “outperform” rating in a research report on Thursday, October 29th. Wells Fargo & Company boosted their price target on Bausch + Lomb from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 29th. Needham & Company LLC reissued a “hold” rating on shares of Bausch + Lomb in a report on Tuesday, September 15th. Evercore set a $17.00 price objective on Bausch + Lomb in a research note on Monday, July 6th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $20.00 price objective on shares of Bausch + Lomb in a report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $20.83.

Bausch + Lomb Stock Performance

Bausch + Lomb stock opened at $20.07 on Tuesday. Bausch + Lomb has a 12-month low of $14.44 and a 12-month high of $21.36. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.55 and a quick ratio of 1.02. The company has a market capitalization of $7.17 billion, a price-to-earnings ratio of -64.76, a price-to-earnings-growth ratio of 0.64 and a beta of 0.56. The firm’s fifty day moving average price is $17.41 and its 200 day moving average price is $16.70.

Institutional Investors Weigh In On Bausch + Lomb

Several institutional investors and hedge funds have recently made changes to their positions in the company. Beach Point Capital Management LP bought a new position in Bausch + Lomb during the third quarter worth $5,882,000. Whitebox Advisors LLC boosted its holdings in Bausch + Lomb by 15.8% in the first quarter. Whitebox Advisors LLC now owns 1,101,854 shares of the company’s stock worth $17,519,000 after purchasing an additional 150,641 shares during the period. Engineers Gate Manager LP acquired a new position in Bausch + Lomb in the second quarter worth $1,479,000. Sei Investments Co. boosted its holdings in Bausch + Lomb by 100.0% in the first quarter. Sei Investments Co. now owns 139,266 shares of the company’s stock worth $2,214,000 after purchasing an additional 69,633 shares during the period. Finally, Counterpoint Mutual Funds LLC bought a new stake in Bausch + Lomb during the third quarter valued at $670,000. 11.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Eschenbach Andrew C. Von sold 6,059 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $16.58, for a total value of $100,458.22. Following the completion of the sale, the director directly owned 63,733 shares of the company’s stock, valued at $1,056,693.14. The trade was a 8.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Frederick Munsch sold 112,015 shares of the company’s stock in a transaction that occurred on Thursday, October 29th. The shares were sold at an average price of $20.48, for a total value of $2,294,067.20. Following the sale, the chief accounting officer owned 45,831 shares in the company, valued at $938,618.88. The trade was a 70.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 183,474 shares of company stock valued at $3,488,437. 1.45% of the stock is owned by corporate insiders.

Key Headlines Impacting Bausch + Lomb

Here are the key news stories impacting Bausch + Lomb this week:

• Positive Sentiment: Strong-buy and momentum rankings: Zacks added BLCO to its Rank #1 (Strong Buy) lists for both momentum and overall stock selection. Zacks also identified the company as a potential long-term value stock, which may attract growth and value-oriented investors. Best Momentum Stock to Buy for November 2nd Why Bausch + Lomb Is a Top Value Stock
• Positive Sentiment: Higher consensus valuation: The consensus price target reportedly increased 10.44% to $21.92, suggesting analysts see additional upside from recent trading levels. Bausch + Lomb Consensus Price Target Raised
• Positive Sentiment: Operating momentum: Highlights from BLCO’s third-quarter earnings call emphasized strong growth. The company previously reported revenue growth of 7.3% year over year and earnings that exceeded analyst expectations, supporting the bullish case. Bausch + Lomb Earnings Call Highlights Strong Growth
• Neutral Sentiment: Mixed analyst signal: HC Wainwright raised its price target to $22 from $21 but downgraded BLCO from Buy to Neutral, indicating improved valuation expectations but less conviction that the stock will materially outperform. HC Wainwright Downgrades Bausch + Lomb
• Negative Sentiment: Insider selling: Chief Accounting Officer Frederick Munsch sold 112,015 shares worth approximately $2.29 million, reducing his holdings by about 71%. While insider sales can be routine, the transaction may concern investors because of its size.

About Bausch + Lomb

Bausch + Lomb Corporation (NYSE: BLCO) is a global eye-health company that develops, manufactures and markets products for vision care, ophthalmic pharmaceuticals and eye surgery. The company serves consumers, eye-care professionals, hospitals and surgical centers through a portfolio spanning contact lenses, contact-lens care products, prescription medicines, over-the-counter eye-care products and surgical equipment.

Its vision-care portfolio includes the Biotrue and INFUSE contact-lens brands, as well as solutions and other products used to clean and maintain contact lenses.